Bruce Isenor v. HHS - Tetanus, Guillain-Barré Syndrome (“GBS”) (2021)
Case summary [AI summaries can sometimes make mistakes]
Bruce Isenor filed a petition on December 30, 2019, alleging that the Prevnar 13 and Tetanus vaccines he received on November 19, 2018, caused him to suffer Guillain-Barré Syndrome (GBS) and its residual effects for more than six months. The respondent denied that the vaccines caused GBS or any other injury.
The parties filed a joint stipulation on June 15, 2021, agreeing to compensation. The stipulation stated that the vaccines are on the Vaccine Injury Table.
The court adopted the stipulation as its decision, awarding a lump sum of $130,000.00 for combined first-year life care expenses, pain and suffering, and past unreimbursable expenses. An additional amount was awarded to purchase an annuity contract.
The case was compensated based on the stipulation. Petitioner counsel was Kathleen M.
Loucks, and respondent counsel was Darryl R. Wishard.
Special Master Christian J. Moran issued the decision on June 17, 2021.
Theory of causation
Petitioner Bruce Isenor alleged that the Prevnar 13 and Tetanus vaccines administered on November 19, 2018, caused Guillain-Barré Syndrome (GBS) and residual effects lasting over six months. The respondent denied causation. The parties submitted a joint stipulation, which the Special Master adopted as the decision. The stipulation indicated that the vaccines are listed on the Vaccine Injury Table. The award included a lump sum of $130,000.00 for first-year life care expenses, pain and suffering, and past unreimbursable expenses, plus an amount to purchase an annuity. The public decision does not detail the specific mechanism of injury, expert testimony, or clinical findings. The case was compensated based on the stipulation. Special Master Christian J. Moran issued the decision on June 17, 2021. Petitioner counsel was Kathleen M. Loucks, and respondent counsel was Darryl R. Wishard.
Source PDFs
USCOURTS-cofc-1_19-vv-01996